{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-100341","form_type":"8-K","ticker":"LITS","cik":"0001262104","company_name":"Lite Strategy, Inc.","filed_at":"2025-07-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.544677+00:00","generated_at":"2026-05-17T22:51:06.553984+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"MEI Pharma reports exercise of pre-funded warrants for 2.08M shares of common stock","bullets":["Investor exercised Pre-Funded Warrants to purchase 2,084,509 shares of common stock on July 24, 2025.","Exercise price paid in cash was $208.45 in aggregate, representing a nominal per-share price.","Warrants were issued under the PIPE Offering initially disclosed on July 17, 2025, with exercise price of $3.4199 per warrant.","Shares were issued in reliance on Section 4(a)(2) and Rule 506(b) of Regulation D exemption."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-100341","json":"https://secwatch.observer/filing/0000950170-25-100341.json","markdown":"https://secwatch.observer/filing/0000950170-25-100341.md","text":"https://secwatch.observer/filing/0000950170-25-100341.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1262104/000095017025100341/0000950170-25-100341-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1262104/000095017025100341/meip-20250724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:51:06.553984+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}